Cover image for GLP-1 Pipeline Update: May 2025 Quarterly view of the GLP-1 pipeline and anticipated indications Prime Therapeutics /glp-1-pipeline-update-may-2025 Prime Therapeutics’ GLP-1...

Cover image for GLP-1 Pipeline Update: February 2025 Quarterly view of the GLP-1 pipeline and anticipated indications Prime Therapeutics /glp-1-pipeline-update-february-2025 Prime Therapeutics’...

Cover image Quarterly view of the GLP-1 pipeline and anticipated indications. Prime Therapeutics /glp-1-pipeline-update-november-2024 Prime Therapeutics’ GLP-1 Pipeline Update focuses on the...

publications GLP-1 Pipeline Update: November 2024 Quarterly view of the GLP-1 pipeline and anticipated indications November 21, 2024 Editorial team Maryam Tabatabai, PharmD Editor-In-Chief Vice...

publications GLP-1 Pipeline Update: February 2025 Quarterly view of the GLP-1 pipeline and anticipated indications February 26, 2025 Editorial team Maryam Tabatabai, PharmD Editor-In-Chief...

Maryam Tabatabai, PharmD, vice president of clinical information, and Carole Kerzic, RPh, drug information pharmacist, share more about glucagon-like peptide-1 (GLP-1) receptor agonists in the drug...

publications GLP-1 Pipeline Update: May 2025 Quarterly view of the GLP-1 pipeline and anticipated indications May 27, 2025 Editorial team Maryam Tabatabai, PharmD Editor-In-Chief Associate Vice...

Someone holds a GLP-1 pen needle in their hands.

Leading GLP-1 persistence, adherence and clinical outcomes research helps inform health plans and members

cover image for the 2025 Spring Prime Therapeutics Report Autoimmune management: Updates and challenges Prime Therapeutics /spring-2025-prime-therapeutics-report The Prime Therapeutics Report is...